Sumitomo Pharma Co., Ltd.
4506
Xếp hạng trong cổ phiếu
#3224
Sumitomo Pharma Co., Ltd. is a global company involved in the creation,... Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across Japan, North America, China, and other international territories. The company's pharmaceutical offerings address a broad spectrum of medical needs. These include treatments for conditions such as Parkinson's disease, depression, type 2 diabetes, systemic fungal infections, hypertension, pruritus, chronic obstructive pulmonary disease (COPD), angina pectoris, and arrhythmia. Additionally, they manufacture atypical antipsychotics, antiepileptics, carbapenem antibiotics, gastrointestinal products, and specialized medications for Anderson-Fabry disease. Beyond healthcare, Sumitomo Pharma provides food components and enhancement agents like polysaccharides, along with savory flavorings such as soups and bouillons. The company also supplies chemical raw materials, which encompass pharmaceutical excipients, components for personal care products, substances used in coatings and industrial applications, and electronic materials. Moreover, it produces veterinary therapeutic solutions designed for domestic pets, specifically dogs and cats, as well as for various farm animals, including cattle, swine, poultry, horses, and cultivated fish. To drive innovation, Sumitomo Pharma fosters partnerships with several organizations. These collaborators include Healios K.K., Keio University, RIKEN, the Center for iPS Cell Research and Application, Kyoto University, and Aikomi Co., Ltd. The company also maintains a joint development agreement with SanBio Company Limited, a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd., and a strategic alliance with Roivant Sciences Ltd. Originally established in 1897, the company, headquartered in Osaka, Japan, was known as Sumitomo Dainippon Pharma Co., Ltd. until it adopted its current name, Sumitomo Pharma Co., Ltd., in April 2022. It functions as a subsidiary of Sumitomo Chemical Company, Limited.
Giá cổ phiếu
$12.27
Vốn hóa thị trường
$5.51B
Thay đổi (1 ngày)
2.20%
Thay đổi (1 năm)
6.72%
Quốc gia
JP
Giao dịch Sumitomo Pharma Co., Ltd. (4506)
Danh mục
Healthcare
EPS của Sumitomo Pharma Co., Ltd. (4506)
EPS tính đến June 2026 TTM: $1.83
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của Sumitomo Pharma Co., Ltd., EPS hiện tại của công ty (TTM) là $1.83. Vào cuối năm 2024, công ty có EPS là $-5.24, tăng so với EPS năm 2023 là $-1.41.
Lịch sử EPS của Sumitomo Pharma Co., Ltd. từ 2005 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $1.83 | 356.38% |
| 2025 | $0.40 | -107.58% |
| 2024 | $-5.24 | 270.82% |
| 2023 | $-1.41 | -221.12% |
| 2022 | $1.17 | -8.72% |
| 2021 | $1.28 | 33.91% |
| 2020 | $0.95 | -13.47% |
| 2019 | $1.10 | -12.92% |
| 2018 | $1.27 | 78.94% |
| 2017 | $0.71 | 28.07% |
| 2016 | $0.55 | 70.42% |
| 2015 | $0.32 | -33.77% |
| 2014 | $0.49 | 82.45% |
| 2013 | $0.27 | 2.48% |
| 2012 | $0.26 | -48.67% |
| 2011 | $0.51 | -9.65% |
| 2010 | $0.56 | 10.43% |
| 2009 | $0.51 | -20.83% |
| 2008 | $0.65 | 33.93% |
| 2007 | $0.48 | 3.92% |
| 2006 | $0.46 | 18.92% |
| 2005 | $0.39 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -69.53% |
IN
|
